摘要
目的:研究我国药品集中招标采购制度的控费效应,为完善我国药品集中招标采购制度提供合理化建议。方法:通过统计学研究,整理分析药品中标价格及药品费用两方面指标数据。结果:药品集中招标采购制度及其相关制度存在缺陷造成控费效应不显著。结论:以"医药、医疗、医保"三医联动为总体方针,对招标采购制度、医疗制度以及医保制度进行完善。
Objective:To analyze the controlling expenditure effect of drug bidding and purchasing system in China,discuss thesystem causes and provide reasonable suggestions for implementing China medicine concentrated bidding and purchasing system.Methods:Through statistical research method,the index data of medicine bidding prices and medicine cost were sorted and analyzed.Results:The controlling expenditure effects of existing disadvantages of medicine concentrated bidding and purchasing system and rel-ative system was obvious.Conclusion:Setting 'medicine,healthcare and medical insurance' association as the general guideline,the purchasing system,medicine system and medical insurance system were implemented.
出处
《中国卫生经济》
北大核心
2015年第10期68-71,共4页
Chinese Health Economics
基金
国家社会科学基金(13BFX120)
关键词
药品招标采购制度
控费效应
带量采购
drug bidding and purchasing system
controlling expenditure effect
amount purchasing
